Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer

Published:2017-04-26 Issue:1 Volume:3 Page:
ISSN:2374-4677
Container-title:npj Breast Cancer
language:en
Short-container-title:npj Breast Cancer

Author:

Solzak Jeffrey P.,Atale Rutuja V.,Hancock Bradley A.,Sinn Anthony L.,Pollok Karen E.,Jones David R.,Radovich Milan

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology

Link

http://www.nature.com/articles/s41523-017-0016-8.pdf

Reference37 articles.

1. Schneider, B. P. et al. Triple-negative breast cancer: risk factors to potential targets. Clin. Cancer Res. 14, 8010–8018 (2008).

2. Dent, R. et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res. 13, 4429–4434 (2007).

3. Carey, L. A. et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295, 2492–2502 (2006).

4. Stark, A. et al. African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study. Cancer 116, 4926–4932 (2010).

5. Huo, D. et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J. Clin. Oncol. 27, 4515–4521 (2009).

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Wnt/β-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumors;Biochemical and Biophysical Research Communications;2024-10

2. Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies;Cancers;2024-07-07

3. Combination Therapy Approach to Overcome the Resistance to PI3K Pathway Inhibitors in Gynecological Cancers;Cells;2024-06-19

4. The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway;Frontiers in Pharmacology;2024-05-09

5. Strategies and techniques for preclinical therapeutic targeting of PI3K in oncology: where do we stand in 2024?;Expert Opinion on Therapeutic Targets;2024-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3